This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

DOAC - prescribing information

Authoring team

This is a summary of the prescribing guidance for DOACs from the Nottinghamshire Area Precscribing Committee (Notts APC).

 

Detailed chart comparing prescribing information for direct oral anticoagulants Rivaroxaban, Apixaban, Dabigatran etexilate, and Edoxaban, including dosages, indications, and administration guidelines from the NHS Nottinghamshire Area Prescribing Committee.

 

Comparison chart detailing the use in hepatic impairment, tablet administration, and compliance considerations for four anticoagulant medications: Rivaroxaban, Apixaban, Dabigatran etexilate, and Edoxaban.

Reference:

  • Notts APC (July 2018). Direct Oral Anticoagulants (DOACs) for treatment of DVT or PE, or prevention against recurrent DVT or PE (in Adults).

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.